(19)
(11) EP 2 943 210 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.01.2018 Bulletin 2018/02

(45) Mention of the grant of the patent:
04.10.2017 Bulletin 2017/40

(21) Application number: 13824661.6

(22) Date of filing: 20.12.2013
(51) International Patent Classification (IPC): 
A61K 35/74(2015.01)
A61P 3/10(2006.01)
 A61P 9/10(2006.01)
A61P 39/06(2006.01)
(86) International application number:
PCT/IB2013/061216
(87) International publication number:
WO 2014/102692 (03.07.2014 Gazette 2014/27)

(54)

LACTOBACILLUS FERMENTUM ME-3 FOR USE IN TREATING METABOLIC SYNDROME RELATED DISEASES

LACTOBACILLUS FERMENTUM ME-3 ZUR VERWENDUNG IN DER BEHANDLUNG VON METABOLISCHEM SYNDROM VERBUNDENEN KRANKHEITEN

LACTOBACILLUS FERMENTUM ME-3 POUR L'UTILSATION DANS LE TRAITEMENT DES MALADIES LIÉES AU SYNDROME MÉTABOLIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.12.2012 GB 201223370

(43) Date of publication of application:
18.11.2015 Bulletin 2015/47

(73) Proprietor: University of Tartu
50090 Tartu (EE)

(72) Inventors:
  • KULLISAAR, Tiiu
    EE-50090 Tartu (EE)
  • ZILMER, Mihkel
    EE-50090 Tartu (EE)
  • SMIDT, Imbi
    EE-50090 Tartu (EE)
  • ZILMER, Kersti
    EE-50090 Tartu (EE)
  • MIKELSAAR, Marika
    EE-50090 Tartu (EE)
  • HÜTT, Pirje
    EE-50090 Tartu (EE)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
US-A1- 2004 071 680
US-A1- 2004 151 708
 US-A1- 2004 126 356
   
  • MARIKA MIKELSAAR ET AL: "Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic", MICROBIAL ECOLOGY IN HEALTH AND DISEASE, vol. 101, no. 10, 1 January 2009 (2009-01-01), pages 4D-27, XP055103173, ISSN: 0891-060X, DOI: 10.1161/CIRCULATIONAHA.106.655688
  • TIIU KULLISAAR ET AL: "An antioxidant probiotic reduces postprandial lipemia and oxidative stress", CENTRAL EUROPEAN JOURNAL OF BIOLOGY, vol. 6, no. 1, 13 November 2010 (2010-11-13), pages 32-40, XP055103171, ISSN: 1895-104X, DOI: 10.2478/s11535-010-0103-4
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).